Exchange Traded Concepts’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,317
| Closed | -$133K | – | 1456 |
|
|
2025
Q1 | $133K | Buy |
12,317
+5,564
| +82% | +$59.9K | ﹤0.01% | 1063 |
|
|
2024
Q4 | $86.4K | Hold |
6,753
| – | – | ﹤0.01% | 1164 |
|
|
2024
Q3 | $186K | Buy |
6,753
+1,836
| +37% | +$50.7K | ﹤0.01% | 984 |
|
|
2024
Q2 | $143K | Sell |
4,917
-1,530
| -24% | -$44.4K | ﹤0.01% | 910 |
|
|
2024
Q1 | $288K | Buy |
6,447
+2,299
| +55% | +$103K | 0.01% | 815 |
|
|
2023
Q4 | $161K | Buy |
4,148
+1,052
| +34% | +$40.8K | ﹤0.01% | 821 |
|
|
2023
Q3 | $91K | Buy |
3,096
+909
| +42% | +$26.7K | ﹤0.01% | 935 |
|
|
2023
Q2 | $139K | Buy |
+2,187
| New | +$139K | ﹤0.01% | 865 |
|